Alicia Bach, MD
Alicia Bach, MD, completed fellowship in 2021 and joined the faculty of the University of Missouri, Columbia, as a pediatric hematologist/oncologist. She completed her medical degree from the University of Texas Medical School at San Antonio, followed by residency in pediatrics at the University of Florida College of Medicine. She was active in both basic and clinical research during her fellowship and has an ongoing clinical interest in sarcomas and palliative care.
Katarina Semkiu, MD
Katarina Semkiu, MD, completed fellowship in 2021 and joined the faculty in the Division of Pediatric Hematology and Oncology at St. Louis Children’s Hospital/Washington University as a member of the Leukemia/Lymphoma team. She received her medical degree from the Loyola University Chicago Stritch School of Medicine, followed by residency and chief residency in pediatrics at Advocate Children’s Hospital in Illinois. Semkiu’s fellowship project centered around medical education, and she maintains a strong interest in this area.
Julia Warren, MD, PhD
Julia Warren, MD, PhD, completed fellowship in 2021 and joined the faculty in the Division of Pediatric Hematology and Oncology at St. Louis Children’s Hospital/Washington University. Warren graduated from the Medical Scientist Training Program at Washington University and pursued residency training in pediatrics at Washington University/St. Louis Children’s Hospital prior to fellowship. She is a physician-scientist with an interest in understanding the genetic causes of bone marrow failure syndromes. For a link to Warren’s publications, click here.
Clare Zimmerman, MD
Clare Zimmerman, MD, completed fellowship in 2021 and joined the faculty of the Southern Illinois University School of Medicine as a pediatric hematologist/oncologist. She received her medical degree from SIU School of Medicine in Springfield, followed by residency in pediatrics at Loyola University Medical Center. She pursued a Master’s of Science in Clinical Investigation during fellowship, and her research focused on the use of cytokine-induced memory-like natural killer cells for the treatment of refractory or relapsed acute myeloid leukemia.
|Past fellow||Graduation||Post-fellowship position|
|Bryan Sisk, MD||2020||Washington University in St. Louis|
|Nicole Brossier, MD, PhD||2019||Washington University in St. Louis|
|Margaret Ferris, MD, PhD||2019||Washington University in St. Louis|
|Stacy Snyder, MD||2019||Beacon Medical Group, Indiana|
|Dan Willis, MD||2019||Washington University in St. Louis|
|Erin Hall, MD||2018||University of Missouri-Kansas City|
|Megan Gauthier, MD||2018||U.S. Food and Drug Agency|
|Steven Allen, MD||2017||University of Pittsburgh Medical Center|
|Cecelia Calhoun, MD, MPH||2017||Washington University in St. Louis|
|Sima Bhatt, MD, MSCI||2017||Washington University in St. Louis|
|Emily Walling, MD||2016||University of Michigan|
|Emily Jen, MD, PhD||2016||U.S. Food and Drug Agency|
|Andrew Cluster, MD||2016||Washington University in St. Louis|
|Angela Herman, MD||2015||OSF HealthCare Children’s Hospital of Illinois|
|Alok Kothari, MD||2015||Washington University in St. Louis|
|Melanie Fields, MD, MSCI||2014||Washington University in St. Louis|
|Alex Ngwube, MD||2014||Stem Cell Transplant Fellowship, Texas Children’s Hospital|
|Melissa Schapiro, MD, MSCI||2014||Memorial Sloan Kettering Cancer Center|